Status:
RECRUITING
Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Cervix Cancer
HPV-Related Malignancy
Eligibility:
FEMALE
18-85 years
Brief Summary
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HP...
Detailed Description
The treatment of invasive cervical cancer is tailored according to the FIGO recommendations. The standard treatment for women with early-stage, (IA2-IB1) cervical cancer is simple or Radical Hysterect...
Eligibility Criteria
Inclusion
- Age Range: 18-85 years old Cervical cancer stage I B 2(Tumor up to 4 cm FIGO 2018) AIS HPV types before and after conization
Exclusion
- Pregnant women under 18 years old. Women who refused to continue to be in study. Women that data about HPV types , final pathology or complication are missing.
Key Trial Info
Start Date :
July 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06196190
Start Date
July 26 2023
End Date
July 1 2028
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Center
Haifa, Israel, 31906